Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Oct 27, 2023; 15(10): 2280-2293
Published online Oct 27, 2023. doi: 10.4240/wjgs.v15.i10.2280
Published online Oct 27, 2023. doi: 10.4240/wjgs.v15.i10.2280
Table 1 Patient demographics
Ref. | Total number of patients | Mean age in years (range) | Gender ratio (M:F) |
Burbidge et al[28], 2013 | 220 | 69 (41-96) | 136:84 |
Li et al[29], 2020 | 385 | - | - |
Davies et al[30], 1997 | 105 | 69 (33-92) | 68:37 |
Kim et al[31], 2009 | 498 | 59.6 (27-89) | 332:166 |
Stell et al[32], 1996 | 103 | 65 (33-91) | 68:35 |
Asencio et al[58], 1997 | 71 | 65.8 (47-81) | 43:27 |
Fujimura et al[59], 2002 | 39 | (26-80) | 17:22 |
Leeman et al[60], 2017 | 74 | 67.6 (29-84) | 54:20 |
Table 2 Tumour characteristics and computed tomography modality used
Ref. | Primary tumour location | Tumour histology | CT modality |
Burbidge et al[28], 2013 | - | Adenocarcinoma (220, 100%) | Multidetector CT with gastric staging protocol |
Li et al[29], 2020 | - | - | Unenhanced, two-phase dynamic enhanced CT |
Davies et al[30], 1997 | - | Adenocarcinoma (105, 100%) | Philips Tomoscan SR 7000 scanner (120 Kvp and 225-300 mAs), contrast enhanced spiral CT |
Kim et al[31], 2009 | - | Intestinal (162, 32.5%) | 16-detector row (n = 427) or 64-detector row (n = 71) scanners |
Diffuse (336, 67.5%) | |||
Stell et al[32], 1996 | Proximal third (60, 58.3%) | Adenocarcinoma (103, 100%) | Contrast-enhanced CT using a GE model 9800 Hilight whole-body scanner (GEC, Milwaukee, Wisconsin, United States) |
Body (24, 23.3%) | |||
Antrum (10, 9.7%) | |||
Body and antrum (6, 5.8%) | |||
Fundus (2, 1.9%) | |||
Linitis plastica (1, 1%) | |||
Asencio et al[58], 1997 | Upper third (12, 17%) | Adenocarcinoma (71, 100%) | Dynamic contrast-enhanced CT |
Middle third (21, 30%) | |||
Lower third (19, 27%) | |||
Fujimura et al[59], 2002 | Japanese classification of gastric carcinoma type 1 (1, 2.6%); type 2 (4, 10.3%); type 3 (14, 35.9%); type 4 (20, 51.3%) | Differentiated (16, 41%) | CT |
Undifferentiated (23, 59%) | |||
Leeman et al[60], 2017 | Proximal (7, 9.5%) | Adenocarcinoma (74, 100%) | Toshiba Aquilion 16 (16 slice), Siemens Somatom Sensation 16 (16 slice), Toshiba Aquilion Multi (4 slice) |
Body (23, 31.1%) | |||
Distal (10, 13.5%) | |||
Linitis plastica (6, 8.1%) |
Table 3 Statistical results of computed tomography and staging laparoscopy
Ref. | Sensitivity | Specificity | Positive predictive value | Negative predictive value | ||||
CT | Staging laparoscopy | CT | Staging laparoscopy | CT | Staging laparoscopy | CT | Staging laparoscopy | |
Burbidge et al[28], 2013 | 25% | - | 99% | - | 83% | - | 82% | - |
Li et al[29], 2020 | 87.5% | - | 76.4% | - | 31.8% | - | - | - |
Davies et al[30], 1997 | 71% | - | 93% | - | 67% | - | 94% | - |
Kim et al[31], 2009 | 28.3% | - | 98.9% | - | - | - | - | - |
Asencio et al[58], 1997 | 0% | 88.9% | - | 100% | - | 100% | - | 95.5% |
Fujimura et al[59], 2002 | 38% | 86% | 100% | 100% | 67% | 92% | - | - |
Leeman et al[60], 2017 | 58.8% | 94.1% | 89.6% | 100% | 66.7% | 100% | 86% | 98% |
False positives | False negatives | |||||||
Stell et al[32], 1996 | 8% | 69% | 100% | 100% | 0% | 0% | 12% | 4% |
Table 4 Patient demographics
Modality | Ref. | Total number of patients | Mean age in years (range) | Gender ratio (M:F) |
PET | Lim et al[11], 2006 | 17 | 51.4 (32-74) | 12:5 |
Sim et al[33], 2009 | 52 | 62 (median) (33-80) | 43:9 | |
Turlakow et al[34], 2003 | 88 | 54 (28-84) | 50:38 | |
Perlaza et al[36], 2018 | 50 | 65.7 ± 12.1 | 30:20 | |
Kim et al[37], 2017 | 60 | 60.6 (29-80) | 16:44 | |
Chen et al[38], 2005 | 68 | 54.8 (28-81) | 49:19 | |
Kim et al[39], 2011 | 139 | 61.5 ± 11.6 | 88:51 | |
MRI | Lin et al[35], 2021 | 62 (11 gastric) | 56 ± 12 (54 ± 13 in gastric) | 20:42 (6:5 in gastric) |
De Vuysere et al[40], 2021 | 32 | (29-85) | 22:10 |
Table 5 Tumour characteristics and computed tomography, positron emission tomography or magnetic resonance imaging modality used
Modality | Ref. | Tumour histology | Specific scanner used | |
CT | PET/MRI | |||
PET | Lim et al[11], 2006 | Moderate differentiation (n = 2) | Single-section spiral CT, HiSpeed CT/I or multi-detector CT scanning fourdetector row, LightSpeed Plus | GE advance PET scanner or Philips Allegro PET system |
Mixed type of moderate and poor differentiation (n = 2) | ||||
Signet cell differentiation (n = 4) | ||||
Poor differentiation (n = 9) | ||||
Sim et al[33], 2009 | Adenocarcinoma (n = 47) | Not mentioned | PET/CT system, Philips Gemini, DA best | |
Signet ring cell (n = 4) | ||||
Unknown (n = 1) | ||||
Turlakow et al[34], 2003 | Gastric (n = 48) | Not mentioned | PET | |
Ovarian (n = 13) | ||||
Adrenocortical (n = 6) | ||||
Mesothelioma (n = 21) | ||||
Perlaza et al[36], 2018 | Well-differentiated (n = 4) | Somatom sensation 64 | Hybrid PET/CT biograph mCT 64S | |
Moderately differentiated (n = 20) | ||||
Poorly differentiated (n = 26) | ||||
Kim et al[37], 2017 | Adenocarcinoma (n = 51) | 16 or 64-detector row CT scanner, LightSpeed 16 or LightSpeed VCT | Discovery ST PET/CT system | |
Signet ring cell carcinoma (n = 5) | ||||
Mucinous carcinoma (n = 4) | ||||
Chen et al[38], 2005 | Adenocarcinoma (n = 13) | Somatom Plus-S or Tomoscan 310 or LightSpeed Plus | GE Advance | |
Undifferentiated adenocarcinoma (n = 55) | ||||
Kim et al[39], 2011 | Adenocarcinoma (n = 117) | Multi-detector row CT scanners, Somatom Volume Zoom | Cyclotron RDS-111 | |
Signet ring cell carcinoma (n = 19) | ||||
Mucinous adenocarcinoma (n = 1) | ||||
Others (n = 2) | ||||
MRI | Lin et al[35], 2021 | Appendiceal (n = 6) | Somatom sensation 64, Aquilion 64 or Aquilion ONE | MRI |
Colon (n = 25) | ||||
Ovarian (n = 20) | ||||
Gastric (n = 11) | ||||
De Vuysere et al[40], 2021 | Adenocarcinoma (n = 9) | Somatom Force | Aera 1.5 T scanner | |
Adenocarcinoma with signet ring cell differentiation (n = 9) |
Table 6 Statistical results of computed tomography and positron emission tomography
Ref. | Sensitivity | Specificity | Positive predictive value | Negative predictive value | Accuracy | True positive/true negative | False positive/false negative | |||||||
CT | PET | CT | PET | CT | PET | CT | PET | CT | PET | CT | PET | CT | PET | |
Lim et al[11], 2006 | 96.5% | 35.3% | 91.6% | 98.9% | - | - | - | - | 89.3% | 89.3% | 13/87 | 6/94 | 8/4 | 1/11 |
Sim et al[33], 2009 | 86.6% | 46.6% | 91.9% | 94.2% | 82.3% | 80% | - | - | - | - | - | - | - | - |
Turlakow et al[34], 2003 | 43% | 57% | - | - | 100% | 93% | - | - | - | - | - | - | - | - |
Perlaza et al[36], 2018 | 64% | 68% | 93% | 100% | - | - | - | - | - | - | - | - | - | - |
Kim et al[37], 2017 | 96% | 50% | 100% | 100% | 100% | 100% | 99% | 89% | 99% | 90% | - | - | - | - |
Chen et al[38], 2005 | 80% | 30% | 91% | 98% | - | - | - | - | 89% | 88% | - | - | - | - |
Kim et al[39], 2011 | 63.6% | 18.2% | 97.7% | 100% | - | - | - | - | 95% | 93.5% | - | - | - | - |
Table 7 Statistical results of computed tomography and magnetic resonance imaging
- Citation: Ho SYA, Tay KV. Systematic review of diagnostic tools for peritoneal metastasis in gastric cancer-staging laparoscopy and its alternatives. World J Gastrointest Surg 2023; 15(10): 2280-2293
- URL: https://www.wjgnet.com/1948-9366/full/v15/i10/2280.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i10.2280